Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis - Scorecard - MDSpire

Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis

  • By

  • Qingyi Mao

  • Beibei Lin

  • Wenluo Zhang

  • Yu Zhang

  • Yue Lei

  • Zhou Zhang

  • Mengque Xu

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Butyrate from Gut Microbiota Reduces Intestinal Inflammation by Enhancing Autophagy Signaling in DSS-Induced Colitis

At a Glance

CategoryDetail
ConditionInflammatory Bowel Disease (IBD)
Key MechanismsButyrate enhances autophagy signaling and restores intestinal barrier function.
Target PopulationPatients with inflammatory bowel disease (IBD) and experimental colitis models.
Care SettingClinical and experimental research settings.

Key Highlights

  • Butyrate levels are significantly lower in IBD patients compared to healthy controls.
  • Oral sodium butyrate treatment improves gut microbiota composition and intestinal barrier function.
  • Enhanced autophagy signaling is observed with butyrate treatment, while autophagy inhibition diminishes protective effects.
  • Dysbiosis characterized by reduced Firmicutes/Bacteroidetes ratio is noted in IBD.
  • Autophagy inducers may serve as potential therapeutic agents for gut inflammation.

Guideline-Based Recommendations

Diagnosis

  • Assess butyrate levels and gut microbiota composition in IBD patients.

Management

  • Consider sodium butyrate supplementation to restore gut microbiota and enhance autophagy.

Monitoring & Follow-up

  • Monitor changes in intestinal barrier function and autophagy markers in response to treatment.

Risks

  • Inhibition of autophagy may exacerbate colonic injury in IBD.

Patient & Prescribing Data

Individuals diagnosed with inflammatory bowel disease (IBD).

Sodium butyrate may improve clinical outcomes by modulating gut microbiota and enhancing autophagy.

Clinical Best Practices

  • Integrate dietary interventions to increase butyrate-producing probiotics.
  • Evaluate the role of autophagy in the management of IBD.
  • Utilize fecal SCFA profiling for personalized treatment strategies.

Related Resources & Content

Original Source(s)

Related Content